Viona Pharmaceuticals is a generic pharmaceutical company focused on marketing and distributing oral solid and topical products. The company states it is headquartered in Cranford, New Jersey and operates as an indirect wholly owned subsidiary of Zydus Lifesciences Limited. Its milestone timeline indicates incorporation in 2018.
Zydus Lifesciences received USFDA final approval for 32 mg bosentan tablets for pediatric PAH and Ammonium Lactate Cream, 12%, while launching an affordable respiratory device in India.
Zydus Lifesciences Limited received final FDA approval for Ammonium Lactate Cream, 12%, a generic of Lac-Hydrin Cream. The topical prescription medication treats xerosis and ichthyosis vulgaris, with annual U.S. sales of $15 million.
